Format
Sort by

Send to

Choose Destination

Selected items

Items: 3

1.

Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.

Vandenbosch K, Renard M, Uyttebroeck A, Sciot R, Matthijs G, Legius E.

Genet Couns. 2005;16(1):95-100.

PMID:
15844786
2.

Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.

Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.

Thyroid. 2017 Dec;27(12):1511-1522. doi: 10.1089/thy.2016.0399. Epub 2017 Nov 3.

PMID:
28946813
3.

An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma.

Cordella D, Muzza M, Alberti L, Colombo P, Travaglini P, Beck-Peccoz P, Fugazzola L, Persani L.

Endocr Relat Cancer. 2006 Sep;13(3):945-53.

PMID:
16954442

Supplemental Content

Support Center